168 related articles for article (PubMed ID: 24532735)
21. Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance.
Permanand G; Mossialos E; McKee M
Clin Med (Lond); 2006; 6(1):87-90. PubMed ID: 16521363
[TBL] [Abstract][Full Text] [Related]
22. British Labour MEP takes over EU medical devices brief.
Watson R
BMJ; 2014 Sep; 349():g5839. PubMed ID: 25248318
[No Abstract] [Full Text] [Related]
23. A safe pair of hands.
Dean E
Nurs Stand; 2014 Jun; 28(39):61. PubMed ID: 24866673
[TBL] [Abstract][Full Text] [Related]
24. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
25. Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.
Kramer DB; Tan YT; Sato C; Kesselheim AS
Food Drug Law J; 2014; 69(1):1-23, i. PubMed ID: 24772683
[TBL] [Abstract][Full Text] [Related]
26. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
27. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
Schott M
Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
[No Abstract] [Full Text] [Related]
28. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
Santoro A; Genov G; Spooner A; Raine J; Arlett P
Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
[TBL] [Abstract][Full Text] [Related]
29. Regulation of medical devices in the European Union.
Chai J
J Leg Med; 2000 Dec; 21(4):537-56. PubMed ID: 11194571
[No Abstract] [Full Text] [Related]
30. Scientific evaluation of spinal implants: an ethical necessity.
Moojen WA; Bredenoord AL; Viergever RF; Peul WC
Spine (Phila Pa 1976); 2014 Dec; 39(26):2115-8. PubMed ID: 25514748
[TBL] [Abstract][Full Text] [Related]
31. Proposed amendments to the medical devices Directives.
Donawa M
Med Device Technol; 2006; 17(1):22-5. PubMed ID: 16483107
[TBL] [Abstract][Full Text] [Related]
32. [Development and evaluation of new drugs and medical devices in Japan--standpoint of regulatory agency].
Maruyama H; Kondo T
Brain Nerve; 2010 Mar; 62(3):263-8. PubMed ID: 20297731
[TBL] [Abstract][Full Text] [Related]
33. European medical device regulatory law and product liability.
Bright J
J Hosp Infect; 1999 Dec; 43 Suppl():S169-73. PubMed ID: 10658776
[TBL] [Abstract][Full Text] [Related]
34. Medicines under additional monitoring in the European Union.
Manso G; Neira F; Ortega S; Martín Arias LH; Sainz M; Salgueiro E
Farm Hosp; 2019 Jan; 43(1):19-23. PubMed ID: 30624169
[TBL] [Abstract][Full Text] [Related]
35. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
36. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
O'Reilly JT
Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
[No Abstract] [Full Text] [Related]
37. Combination products: modernizing the regulatory paradigm.
Hunter NL; Sherman RE
Nat Rev Drug Discov; 2017 Aug; 16(8):513-514. PubMed ID: 28496147
[TBL] [Abstract][Full Text] [Related]
38. Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication.
Varallo FR; Forgerini M; Herdeiro MT; de Carvalho Mastroianni P
Clin Ther; 2019 Mar; 41(3):598-603. PubMed ID: 30792075
[TBL] [Abstract][Full Text] [Related]
39. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
Mottes LM
Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761
[No Abstract] [Full Text] [Related]
40. Analysis of the renewed European Medical Device Regulations in the frame of the non - EU regulatory landscape during the COVID facilitated change.
Kanti SPY; Csóka I; Adalbert L; Jójárt-Laczkovich O
J Pharm Sci; 2022 Oct; 111(10):2674-2686. PubMed ID: 35872025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
